Medindia

X

Anthony Vuolo Appointed Chief Financial Officer of WebMD

Wednesday, November 4, 2009 General News J E 4
Advertisement


NEW YORK, Nov. 2 WebMD Health Corp. (Nasdaq: WBMD) announced today that Anthony Vuolo, its Chief Operating Officer, has been appointed to the additional position of Chief Financial Officer. Mr. Vuolo previously served as WebMD's Chief Financial Officer from its initial public offering in 2005 until becoming Chief Operating Officer in 2007. He has served in senior financial, operational and business development positions with WebMD and predecessor companies for more than 15 years.

Mr. Vuolo is replacing Mark D. Funston, who is leaving the Company to pursue other opportunities.

Martin J. Wygod, Chairman of the Board of WebMD, stated: "On behalf of the Company, I want to thank Mark for his contributions and wish him well in his future endeavors." Mr. Wygod also stated: "Tony has a strong financial background and has been a proven leader in the various positions he has held."

About WebMD

WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. Approximately 60 million unique visitors access the WebMD Health Network each month.

The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, eMedicine, eMedicine Health, RxList and theHeart.org.

All statements contained in this press release, other than statements of historical fact, are forward-looking statements. These statements speak only as of the date of this press release and are based on our current plans and expectations, and they involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: market acceptance of our products and services; relationships with customers and strategic partners; and changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet and information technology industries. Further information about these matters can be found in our Securities and Exchange Commission filings.

SOURCE WebMD
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Dendreon Completes Submission of Biologics License...
S
Quark Pharmaceuticals to Present Data on its siRNA...